tag@treatmentactiongroup.org

Global

Act Now: End AIDS and TAG Warn Against Erasure of Black HIV Awareness, Call for Action on National Black HIV/AIDS Awareness Day

  • Jason Kirk

This National Black HIV/AIDS Awareness Day, Act Now: End AIDS and TAG uplift the truth: Black people are disproportionately impacted by HIV, and equity-driven solutions are essential. Ending the HIV epidemic requires confronting racism, expanding access to prevention and care, and ensuring that Black communities are centered, visible, and supported in public health efforts.

Read more

Research Toward a Cure Trials

  • Dorrit Walsh

The monthly update of TAG's listing of clinical trials and observational studies related to the research effort to cure HIV infection, mainly derived from the clinicaltrials.gov online registry.

Read more

This Year, Our Board Saw Firsthand What We Are Up Against

  • Jason Kirk

This year revealed how far this administration is willing to go in undermining public health. The White House refused to recognize World AIDS Day. Global and domestic HIV, TB, and HCV programs were directly threatened, and many were terminated. Senior CDC leaders resigned rather than carry out political firings or oversee the degradation of national vaccine guidance. And in August, a vigilante encouraged by political rhetoric fired nearly 500 rounds into the CDC campus in Atlanta and killed a police officer. The President has still not publicly acknowledged the attack.

Read more

TAGLine 2025: A Year of Action

  • Jason Kirk

TAGLine 2025 documents a year of action as Treatment Action Group defended science, confronted attacks on public health, and fought to protect communities impacted by HIV, TB, and HCV.

Read more

New Report Urges Action to Ensure Sustainable, Affordable Supply of Key Vaccine Adjuvants for Global Health Use

  • Dorrit Walsh

Behind many lifesaving vaccines is a fragile supply chain that few people ever see. This new TAG report examines how weaknesses in the production and supply of key vaccine adjuvants (an ingredient that enhances the immune response) can create bottlenecks that threaten global access to vaccines, underscoring the importance of greater market transparency, security, and competitiveness among governments, funders, and pharmaceutical companies.

Read more

Debt and Its Impacts on TB and HIV Investment

  • Dorrit Walsh

Public financing and domestic resources for health are straining under debt burdens as countries struggle to build up domestic revenues in the face of weak tax systems and volatile markets.

Read more
Back To Top